Timothy Robinson
Analyst · Canaccord Genuity. Please go ahead
Thank you, Mike. I’d now like to review our performance for the quarter ended June 30, 2015 in more detail. Please note that the financial information I reference today will focus on our results from continuing operations. For the second quarter of 2015, income from discontinued operations, net of tax, was $400,000. In the second quarter, net revenue decreased 3.3% to $72.2 million from net revenue of $74.7 million in the second quarter last year. The Take Shape For Life sales channel accounted for approximately 72.4% of revenue, the Medifast Direct channel accounted for 19%, the Franchise Medifast Weight Control Centers channel accounted for 6.5% and the Medifast Wholesale channel accounted for 2.1% of net revenue. Focusing on our sales channels in more detail, revenue in direct sales channel, Take Shape For Life, decreased approximately 3.1% to $52.3 million compared to the same period last year. The decrease in revenue for this channel is primarily driven by a decrease in the number of health coaches, as compared to the second quarter of the prior year, an offset by an increase in the average revenue per Health Coach. This revenue resulted we marked the second consecutive quarterly improvement in the rate of decline on our way to resuming growth. We ended the second quarter with approximately 11,800 active health coaches and the average revenue per health coach per quarter was $4,423. While this marks a slight decline from the first quarter active Health Coach count we continue to be very encouraged by the improvement in newly sponsored coaches so far this year. Our improved coach sign up process and our increased focus on business building are having a positive impact. Our Medifast Direct segment revenue decreased 10% to $13.7 million, as compared to $15.2 million in the second quarter of 2014. While still a decline, this marks the fourth consecutive quarterly improvement in the rate of decline and results were in line with our expectations. Revenue in the Franchise Medifast Weight Control Centers channel increased to $4.7 million in the second quarter from $3.8 million, for an increase of 22.3% as compared to the same period last year. The increase was driven by the conversion of corporate centers to franchise centers, partially offset by franchise center closures and the decrease in sales franchise centers open greater than one year. We ended the quarter with 52 franchise centers in operation compared to 73 centers at the end of the same period last year. Wholesale channel revenues, which is comprised of revenues from physicians and other wholesale partners decreased to $1.5 million, compared to $1.7 million last year. This decrease was fueled by the loss of few large accounts resulting from Medifast enforcement of business partner compliance requirements. Gross profit for the second quarter of 2015 was $53.2 million, compared to $55.6 million in the second quarter of the prior year. Our gross profit margin decreased 70 basis points to 73.7% versus 74.4% in the second quarter of 2014, so it increased from 73.3% in the first quarter of this year. The decrease in the prior year was primarily the result of an increase in cost for certain more ingredients, higher manufacturing variants due to reduced volumes, and in increase in obsolescence for single products due to expiration dates. These cost increase was partially offset by price increases initiated at the end of the first quarter. Selling, general and administrative expenses in the second quarter of 2015 were $44.5 million versus $45.7 million in the second quarter last year, a decrease of $1.2 million. As a percentage of net revenue, selling, general and administrative expenses were 61.7%, up from 61.2% in the second quarter of 2014. Second quarter 2015 selling, general and administrative expenses include $300,000 in extraordinary legal and advisory expenses, resulting from 13D filings. Excluding these items, selling, general and administrative expenses as a percentage of sales would have been 61.3% in the second quarter of 2015, which is consistent with the prior year. Sales and marketing expense decreased by $800,000 in the second quarter of 2015 as compared to the second quarter of 2014. This was primarily driven by a decrease in advertising spending partially offset by new Take Shape For Life conventional centers earned during the quarter. Second quarter operating income from continuing operations before tax was $8.8 million, or 12.2% of net revenue as compared to $10.1 million or 13.5% net revenue in the second quarter of 2014. Second quarter income from continuing operating net of tax was $5.8 million or $0.48 per diluted share based on approximately 12.2 million shares outstanding compared to $6.6 million or $0.50 per diluted share for the comparable quarter last year, based on approximately 13.1 million shares outstanding. Excluding expenses associated with extraordinary, legal and advisory expenses is resulting from 13D filings income from continuing operations would have been $6 million or $0.50 per diluted share. Our effective tax rate was 33.8% compared to 34.4% in the second quarter of 2014. This decrease is largely due to an increase in permanent differences, which were primarily driven by higher taxes and interest income and partially offset by an increase in state income taxes. Our balance sheet remains strong as stockholders' equity of $88.2 million and working capital of $63.3 million as of June 30, 2015. Cash, cash equivalents and investments securities for the second quarter of 2015 increased to $65 million compared to $61.4 million at March 31, 2015. We repurchased approximately 100,000 shares during the second quarter and we currently have 1.1 million share authorization for repurchase as of June 30, 2015. Now turning to our guidance. We expect the third quarter net revenue from continuing operations to be in the range of $65 million to $68 million and earnings per diluted share from continuing operations to be in the range of $0.40 to $0.043 per diluted share. We now expect full year revenue from continuing operations to be in the range of $270 million to $280 million and full year earnings per diluted share from continuing operations to be in the range of $1.70 to $1.80. Our revised full year guidance reflects the decrease in the revenue forecasted from a Medifast direct channel in part due to the delayed timing of several e-commerce initiatives that are now expected to launch in the late third quarter. Additionally, the unexpected closure of eight Medifast franchise weight control centers is factored into our second half projections as well as the impact of our enforcement of business partner from client’s requirements within the wholesale business. It's important to note however, that we continue to be optimistic regarding improvements expected to Take Shape for Life in the second half. Fiscal year guidance excludes expenses resulting from 13D filings. We do not anticipate any additional expenses resulting 13D filing for the balance of the year. So that concludes our financial overview. Now I'd like to turn the call back over to Chairman and CEO, Mike MacDonald.